Found: 40
Select item for more details and to access through your institution.
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design.
- Published in:
- EP: Europace, 2012, v. 14, n. 4, p. 528
- By:
- Publication type:
- Article
Secondary Prevention in Concurrent Coronary Artery, Cerebrovascular, and Chronic Kidney Disease: Focus on Pharmacological Therapy.
- Published in:
- Cardiovascular Therapeutics, 2009, v. 27, n. 3, p. 199, doi. 10.1111/j.1755-5922.2009.00087.x
- By:
- Publication type:
- Article
Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2022, v. 63, n. 2, p. 345, doi. 10.1007/s10840-021-00989-x
- By:
- Publication type:
- Article
Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.
- Published in:
- Clinical Cardiology, 2016, v. 39, n. 6, p. 345, doi. 10.1002/clc.22537
- By:
- Publication type:
- Article
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
- Published in:
- European Heart Journal, 2024, v. 45, n. 26, p. 2336, doi. 10.1093/eurheartj/ehae319
- By:
- Publication type:
- Article
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 9, p. 1053, doi. 10.1093/eurjhf/hft111
- By:
- Publication type:
- Article
Warfarin Therapy and Systolic Hypertension in Men With Atrial Fibrillation
- Published in:
- American Journal of Hypertension, 2005, v. 18, n. 12, p. 1592, doi. 10.1016/j.amjhyper.2005.06.001
- By:
- Publication type:
- Article
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 285, n. 13, p. 1711, doi. 10.1001/jama.285.13.1711
- By:
- Publication type:
- Article
Preventing Stroke in Patients With Atrial Fibrillation.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 281, n. 19, p. 1830, doi. 10.1001/jama.281.19.1830
- By:
- Publication type:
- Article
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.
- Published in:
- European Heart Journal, 2005, v. 26, n. 9, p. 890, doi. 10.1093/eurheartj/ehi186
- By:
- Publication type:
- Article
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2018, v. 46, n. 4, p. 435, doi. 10.1007/s11239-018-1715-1
- By:
- Publication type:
- Article
Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 9, p. e2015943, doi. 10.1001/jamanetworkopen.2020.15943
- By:
- Publication type:
- Article
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS<sub>2</sub> Score: A Subgroup Analysis of the RE-LY Trial.
- Published in:
- Annals of Internal Medicine, 2011, v. 155, n. 10, p. 660, doi. 10.7326/0003-4819-155-10-201111150-00004
- By:
- Publication type:
- Article
Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation.
- Published in:
- Pacing & Clinical Electrophysiology, 2001, v. 24, n. 9, p. 1435, doi. 10.1046/j.1460-9592.2001.01435.x
- By:
- Publication type:
- Article
Central Clinical Research Issues in Electrophysiology: Report of the NASPE Committee.
- Published in:
- Pacing & Clinical Electrophysiology, 2001, v. 24, n. 4, p. 526, doi. 10.1046/j.1460-9592.2001.00526.x
- By:
- Publication type:
- Article
Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 1999, v. 4, n. 1, p. 3, doi. 10.1177/107424849900400102
- By:
- Publication type:
- Article
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
- Published in:
- European Heart Journal, 2020, v. 41, n. 41, p. 4037, doi. 10.1093/eurheartj/ehaa697
- By:
- Publication type:
- Article
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2959, doi. 10.1093/eurheartj/ehy148
- By:
- Publication type:
- Article
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
- Published in:
- European Heart Journal, 2018, v. 39, n. 6, p. 477, doi. 10.1093/eurheartj/ehx584
- By:
- Publication type:
- Article
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
- Published in:
- European Heart Journal, 2017, v. 38, n. 12, p. 860, doi. 10.1093/eurheartj/ehw069
- By:
- Publication type:
- Article
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
- Published in:
- European Heart Journal, 2017, v. 38, n. 12, p. 852, doi. 10.1093/eurheartj/ehv643
- By:
- Publication type:
- Article
The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- letter
Human Platelets Labeled with In-111 8-Hydroxyquinoline: Kinetics, Distribution, and Estimates of Radiation Dose.
- Published in:
- Journal of Nuclear Medicine, 1982, v. 23, n. 2, p. 149
- By:
- Publication type:
- Article
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
- Published in:
- European Heart Journal, 2014, v. 35, n. 47, p. 3346, doi. 10.1093/eurheartj/ehu367
- By:
- Publication type:
- Article
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa).
- Published in:
- European Heart Journal, 2013, v. 34, n. 20, p. 1498, doi. 10.1093/eurheartj/eht039
- By:
- Publication type:
- Article
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 9, p. 2112, doi. 10.1093/cvr/cvab262
- By:
- Publication type:
- Article
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 1, p. 295, doi. 10.1093/cvr/cvaa344
- By:
- Publication type:
- Article